On the afternoon of August 5th, Shanghai held the 5th session of Biomedical Industry Salon, i.e., mRNA Industry Chain Seminar. This event brought together mRNA industry experts, upstream and downstream enterprises and investment institutions to focus on the whole industrial chain through sharing and exchange, striving to improve the quality and efficiency of the industry, and helping Shanghai build a world-class biomedical industry cluster.
At the seminar, Everbright Securities and StemiRNA gave keynote speeches on the overall trend of vaccine industry, R&D of mRNA vaccine for COVID-19 and industrialization progress. Representatives from Tofflon, Hongene Biotech, Duoning Biotechnology, Kactus, PRGENE and E Fund had in-depth discussions on the opportunities and challenges of mRNA industry chain and development.
In recent years, mRNA drugs have shown important application potentials in infectious disease prevention, cancer and rare disease treatment. Innovative pharmaceutical companies all over the world are competing to invest in R&D in related fields, which is also a frontier field supported by Shanghai.
Biomedical Industry Salon is a series of events sponsored by Shanghai Biomedical Industry Development Leading Group Office, focusing on serving the development of biomedical industry, and regularly holding activities with different themes and forms. This event was hosted by Shanghai Biomedical Industry Promotion Center.
